Page results
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
Latest news and developments in the Macmillan Support and Information Service
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Information about staff who work in the Macmillan Support and Information Service.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
File results
-
FOI/2022/0800 - Day unit/ outpatient unit for haematology patients
-
FOI/2022/0797 - Information Governance and Corporate Governance personnel
-
FOI/2022/0796 - Procedures performed for various bone biopsies/ treatments
-
FOI/2022/0795 - Mobile software (communications, chat, photo) used by the Trust
-
FOI/2022/0794 - Communication personnel and communication spend
-
FOI/2022/0793 - Post Covid-19 assessment service and related data collection
-
FOI/2022/0791 - Software used for cleanliness/ estates audits, high impact interventions and surgical site surveillance
-
FOI/2022/0772 - Treatments for rare diseases
-
FOI/2022/0770 - Parking operations, impact, and parking charge notices issued
-
FOI/2022/0768 - Patients treated for Haemophila A